New drug combo shows promise for Hard-to-Treat cancers
NCT ID NCT06271837
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 20 times
Summary
This study tests a drug called trastuzumab deruxtecan (T-DXd), alone or with other cancer drugs, in people with advanced solid tumors that have a protein called HER2. The goal is to see if the drug shrinks tumors or slows their growth. About 127 adults with tumors that cannot be surgically removed or have spread will take part. The study is open-label, meaning everyone knows what treatment they receive.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS (EXCLUDING GASTRIC CANCER AND BREAST CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Beijing, 100142, China
-
Research Site
Beijing, 100191, China
-
Research Site
Changchun, 130021, China
-
Research Site
Changsha, 410013, China
-
Research Site
Chengdu, 610041, China
-
Research Site
Chongqing, 400030, China
-
Research Site
Dongyang, 322100, China
-
Research Site
Guangzhou, 510145, China
-
Research Site
Guangzhou, 510630, China
-
Research Site
Hangzhou, 310003, China
-
Research Site
Hangzhou, 310016, China
-
Research Site
Hangzhou, 310022, China
-
Research Site
Harbin, 150081, China
-
Research Site
Hefei, 230031, China
-
Research Site
Kunming, 650118, China
-
Research Site
Lishui, 323000, China
-
Research Site
Nanchang, 330029, China
-
Research Site
Shandong, China
-
Research Site
Shanghai, 200001, China
-
Research Site
Shanghai, 200011, China
-
Research Site
Shanghai, 200032, China
-
Research Site
Shenyang, 110016, China
-
Research Site
Taiyuan, 030001, China
-
Research Site
Wuhan, 430022, China
-
Research Site
Xi'an, 710061, China
-
Research Site
Xuzhou, 221009, China
-
Research Site
Yinchuan, 750004, China
-
Research Site
Zhengzhou, 450002, China
-
Research Site
Zhengzhou, 450008, China
Conditions
Explore the condition pages connected to this study.